People: aTyr Pharma Inc (LIFE.OQ)
14 Dec 2018
Mr. Grove Matsuoka is Senior Vice President, Product Programs and Planning of the Company. Mr. Matsuoka served as Senior Vice President, Commercialization at CoDa Therapeutics, Inc., a biopharmaceutical company, from 2007 to 2016, where he led the development of commercialization plans for novel cellular gap junction modulating platform technology through in-depth assessment of the market, competitive environment, regulatory and market access hurdles. Prior to that, from 1995 to 2007, he worked in various positions at Amgen, Inc., most recently as Director, Medical Affairs, Strategic Planning and Operations, where he established and managed the strategic and operational function for the newly formed Medical Affairs organization. Mr. Matsuoka was also Clinical Research Project Team Leader for an Fc Fusion Program while at Amgen. He received his M.B.A. from Boston College and his B.A. in Microbiology and Immunology from University of California, Berkeley.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|